Public Joint-Stock Company "Human Stem Cells Institute" (MISX:ISKJ) and Artur Isaev acquired 17.79% interest in GENETICO LLC from RVC Biopharmaceutical Investments, Limited liability Company, managed by RVC (OJSC), Investment Arm on November 26, 2020. In the future, the RVC Biofund package would be divided and its ultimate owners would be Public Joint-Stock Company "Human Stem Cells Institute" (MISX:ISKJ)(IceGen-2 LLC) - 10% and Artur Isaev - 7.79%. Public Joint-Stock Company "Human Stem Cells Institute" (MISX:ISKJ) and Artur Isaev completed the acquisition of 17.79% interest in GENETICO LLC from RVC Biopharmaceutical Investments, Limited liability Company, managed by RVC (OJSC), Investment Arm on November 26, 2020.